196 related articles for article (PubMed ID: 6796316)
1. Selective deficiency of the fourth component of complement in a patient with systemic lupus erythematosus (SLE): immunochemical and biological studies.
Minta JO; Urowitz MB; Gladman DD; Irizawa T; Biggar WD
Clin Exp Immunol; 1981 Jul; 45(1):72-80. PubMed ID: 6796316
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus in a patient with C4 deficiency.
Urowitz MB; Gladman DD; Minta JO
J Rheumatol; 1981; 8(5):741-6. PubMed ID: 6975824
[TBL] [Abstract][Full Text] [Related]
3. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
[TBL] [Abstract][Full Text] [Related]
4. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
Perez HD; Lipton M; Goldstein IM
J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
[TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative complement pathway in systemic lupus erythematosus.
Wilson MR; Arroyave CM; Nakamura RM; Vaughan JH; Tan EM
Clin Exp Immunol; 1976 Oct; 26(1):11-20. PubMed ID: 826360
[TBL] [Abstract][Full Text] [Related]
6. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus.
Jackson CG; Ochs HD; Wedgwood RJ
N Engl J Med; 1979 May; 300(20):1124-9. PubMed ID: 431636
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
8. Partial C4 deficiency in two children with systemic lupus erythematosus.
Bakkaloğlu A; Pascual M; Schifferli JA; Ozen S; Beşbaş N; Saatçi U
Turk J Pediatr; 1995; 37(2):147-51. PubMed ID: 7597765
[TBL] [Abstract][Full Text] [Related]
9. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
Håkansson L; Hällgren R; Venge P
Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
[TBL] [Abstract][Full Text] [Related]
11. Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).
Hurst NP; Nuki G; Wallington T
Clin Exp Immunol; 1984 Feb; 55(2):303-12. PubMed ID: 6697566
[TBL] [Abstract][Full Text] [Related]
12. [Lupus and protein deficiencies of the classical complement pathway].
Weiss L; Maillet F; Kazatchkine M
Rev Prat; 1990 Sep; 40(21):1937-40. PubMed ID: 2237185
[TBL] [Abstract][Full Text] [Related]
13. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
14. Serum heat-labile opsonins in systemic lupus erythematosus.
Jasin HE; Orozco JH; Ziff M
J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of C2, the second complement component, in the family of a patient with SLE-like syndrome: the first case of hereditary C2 deficiency in Czechoslovakia.
Starsia Z; Zitnan D; Loos M; Stefanovic J; Bosák V; Niks M; Tomanová H; Lukác J; Lulovicová M
Haematologia (Budap); 1987; 20(4):215-20. PubMed ID: 3428724
[TBL] [Abstract][Full Text] [Related]
16. [Systemic lupus erythematosus in hereditary complement 4 deficiency].
Klein G; Tappeiner G; Hintner H; Scholz S; Wolff K
Hautarzt; 1984 Jan; 35(1):27-32. PubMed ID: 6706571
[TBL] [Abstract][Full Text] [Related]
17. Partial deficiency of the fourth component of human complement (C4) and autoantibody directed against C4 in a patient with SLE.
Ripoche J; Fontaine M; Godin M; Hauptmann G; Goetz J
Ann Immunol (Paris); 1983; 134D(2):233-45. PubMed ID: 6559049
[TBL] [Abstract][Full Text] [Related]
18. Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.
Jasin HE
J Clin Invest; 1977 Sep; 60(3):709-15. PubMed ID: 893674
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil chemotaxis and serum chemotactic activity in systemic lupus erythematosus.
Alvarez I; Vazquez JJ; Fontan G; Gil A; Barbado J; Ojeda JA
Scand J Rheumatol; 1978; 7(2):69-74. PubMed ID: 705269
[TBL] [Abstract][Full Text] [Related]
20. Subtotal C4 deficiency and SLE-like disease.
Irestedt M; Svensson A; Månsson T
Acta Derm Venereol; 1986; 66(1):67-70. PubMed ID: 2424221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
